StreetAlpha.app
Home › Stocks › XAIR

Beyond Air, Inc. (XAIR)

$2.01
▼ −0.50%
LAST CLOSE · NOV 17

Beyond Air makes the LungFit PH system, a medical device that generates nitric oxide from room air for hospital use. It last closed at $2.01 on Nov 17, down 0.50% on the day. XAIR reports earnings on Thu, Feb 11, 2027.

AI Auto Pilots
Is XAIR in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$8.2M
+41.2% vs a year ago
Net income
−$33.4M
−407.3% margin
Free cash flow
−$21.2M
−259.0% margin
Gross margin
10.0%
$816K gross profit
Valuation
Market cap
$3.3M
1.7M shares
P/E
–
Price to sales
0.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$5.4M
At Sep 30
Shareholder equity
$5.3M
Shares outstanding
1.7M
At Nov 10
Fiscal year endsMarch
ExchangeNasdaq
Financials history
FY2024: $1.2M$1.2MFY2024FY2025: $3.7M$3.7MFY2025FY2026: $7.7M$7.7MFY2026

From XAIR's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
-$2.17
$2.2M revenue est.
Year-ago EPS
-$0.85
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated XAIR in the past 90 days, not enough for a consensus
Average 12-month target
$10.00
▲ 397.5% upside

Based on 1 analyst who set a price target on XAIR in the past 90 days. The average target is $10.00, with a high of $10.00 and a low of $10.00, compared with the last close of $2.01.

Low $10.00Avg $10.00High $10.00
Blue marker: last close $2.01
Highest target$10.00
Average target$10.00
Lowest target$10.00
Latest rating changes
Lake StreetInitiated
Sep 1Buy$10
DateFirmActionRatingPrice target
Sep 1Lake StreetInitiatedBuy$10
Loading…

Technical Analysis

XAIR · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 12% below its 20 day and 26% below its 50 day average. It is 337% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 38), near oversold. The nearest support is the Pivot at $2.00, and the nearest resistance the Pivot R1 at $2.06.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNear oversold
VolatilityHigh, 13.6%/day
Key levels
$53.2052 week high+2546.8%
$8.78200 day average+336.8%
$4.26100 day average+111.9%
$2.5450 day average+26.4%
$2.34Swing high (Oct 21)+16.4%
$2.2520 day average+11.9%
$2.06Pivot R1+2.5%
$2.01Last close
$2.00Pivot−0.5%
$1.95Pivot S1−3.0%
$1.8552 week low−8.0%
$1.85Swing low (Nov 12)−8.0%
Indicators
RSI (14)37.69Weak, oversold below 30Neutral
MACD-0.13Above its signal lineBullish
Stochastic12.4Near the bottom of its rangeOversold
ADX (14)22.3Weak trend
Williams %R-90.3Oversold below −80, overbought above −20Oversold
CCI (20)-150.8Oversold below −100, overbought above 100Oversold
Rate of change−13.4%Change over 10 sessionsBearish
ATR (14)$0.27Typical daily range, 13.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XAIR

What happened before

See how XAIR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow XAIR usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How XAIR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in XAIR in the last 90 days.

Loading…

See today’s whale options flow across the market →

XAIR Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲22 buying vs 1 selling
  • ▲Held by funds +13.1 pts
  • ▲Funds holding +21
  • ●No superinvestor moves
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding221+2100.0%
In funds' top 1000–
Held by funds13.1%0.0%+13.1 pts
New / increased22 / 01 / 0+2100.0%
Reduced / sold out0 / 10 / 0–
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See XAIR institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XAIR is in one of them and how their past XAIR trades turned out.

XAIR in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered XAIR in an article yet. Here's the latest on the wider market.

About Beyond Air

Beyond Air is a medical device and biopharmaceutical company based in Garden City, New York. Its main product is the LungFit PH system, which makes nitric oxide from ambient air and delivers it to patients through a ventilator or directly to the lungs. Hospitals use the device to treat newborn infants with a serious breathing condition caused by high blood pressure in the lung arteries. The company is also developing related systems for lung infections and has other programs aimed at cancer and neurological conditions.

Headquarters
Garden City, NY